{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T12:26:12Z","timestamp":1788265572176,"version":"build-2803163510"},"reference-count":33,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr. Issues Mol. Biol.","CIMB"],"abstract":"<jats:p>Telomerase is an interesting biological target for cancer treatment. Despite recent advances in telomerase research and the rapid development of new methodologies, significant challenges remain in identifying effective telomerase inhibitors with anticancer activity. In this manuscript, we provide computational studies to analyse how structural modification of BIBR1532, a selective and non-competitive telomerase inhibitor, may affect binding by a newly reported human telomerase model. BIBR1532 has been extensively studied in various cancer types, but analyses have shown its low anticancer activity. Further modification of BIBR1532 yielded compound BIBR1591 through a lipophilic morpholine ring extension of the benzoic acid. Interestingly, BIBR1591 showed approximately five-fold weaker inhibitory activity toward human telomerase relative to BIBR1532, but its in vivo preclinical studies have demonstrated significant anti-tumour and pro-apoptotic efficacy. Despite promising preclinical activities, neither compound has advanced to clinical trials, reportedly due to challenges with its pharmacokinetic properties. BIBR1532 suffers from poor solubility and low cellular uptake. This manuscript aims to provide an updated overview of human telomerase inhibition by BIBR1532 analogues and emphasise the importance of understanding its molecular mode of action based on the most updated literature. Using an in silico approach, we analysed how the structural modification of the BIBR scaffold influences the binding mode at the BIBR binding site recently discovered in the structure of human telomerase. We have also assessed whether reported analogues offer a measurable advantage over the parent compound.<\/jats:p>","DOI":"10.3390\/cimb48090893","type":"journal-article","created":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T11:33:32Z","timestamp":1788262412000},"page":"893","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The Different Faces of the Selective Human Telomerase Inhibitor: BIBR1532 and Its Derivatives"],"prefix":"10.3390","volume":"48","author":[{"given":"Micha\u0142","family":"Kosno","sequence":"first","affiliation":[{"name":"2nd Department of Radiology, Medical University of Gda\u0144sk, Mariana Smoluchowskiego 17, 80-210 Gda\u0144sk, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9942-285X","authenticated-orcid":false,"given":"Natalia","family":"Maciejewska","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Technology and Biochemistry, Faculty of Chemistry, Gda\u0144sk University of Technology, 11\/12 Narutowicza Str., 80-233 Gda\u0144sk, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamila","family":"Wolska","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Technology and Biochemistry, Faculty of Chemistry, Gda\u0144sk University of Technology, 11\/12 Narutowicza Str., 80-233 Gda\u0144sk, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0833-5596","authenticated-orcid":false,"given":"Iwona","family":"Gabriel","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Technology and Biochemistry, Faculty of Chemistry, Gda\u0144sk University of Technology, 11\/12 Narutowicza Str., 80-233 Gda\u0144sk, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,9,1]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/s41576-019-0099-1","article-title":"Telomeres and telomerase: Three decades of progress","volume":"20","author":"Shay","year":"2019","journal-title":"Nat. Rev. Genet."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"a041703","DOI":"10.1101\/cshperspect.a041703","article-title":"Telomerase in cancer therapeutics","volume":"16","author":"Siteni","year":"2024","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/0022-2836(92)90096-3","article-title":"Telomere end-replication problem and cell aging","volume":"225","author":"Levy","year":"1992","journal-title":"J. Mol. Biol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/345458a0","article-title":"Telomeres shorten during ageing of human fibroblasts","volume":"345","author":"Harley","year":"1990","journal-title":"Nature"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/0092-8674(85)90170-9","article-title":"Identification of a specific telomere terminal transferase activity in Tetrahymena extracts","volume":"43","author":"Greider","year":"1985","journal-title":"Cell"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"a003558","DOI":"10.1101\/cshperspect.a003558","article-title":"Telomerase: An RNP enzyme synthesizes DNA","volume":"3","author":"Blackburn","year":"2011","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1146\/annurev-biochem-061516-045019","article-title":"Telomerase mechanism of telomere synthesis","volume":"86","author":"Wu","year":"2017","journal-title":"Annu. Rev. Biochem."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/s41586-018-0062-x","article-title":"Cryo-EM structure of substrate-bound human telomerase holoenzyme","volume":"557","author":"Nguyen","year":"2018","journal-title":"Nature"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/s41580-020-0234-z","article-title":"Regulation of human telomerase in homeostasis and disease","volume":"21","author":"Roake","year":"2020","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/S0959-8049(97)00062-2","article-title":"A survey of telomerase activity in human cancer","volume":"33","author":"Shay","year":"1997","journal-title":"Eur. J. Cancer"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0092-8674(03)00550-6","article-title":"Telomerase maintains telomere structure in normal human cells","volume":"114","author":"Masutomi","year":"2003","journal-title":"Cell"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s13073-016-0324-x","article-title":"Roles of telomeres and telomerase in cancer, and advances in telomerase-targeted therapies","volume":"8","author":"Jafri","year":"2016","journal-title":"Genome Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/S0960-894X(03)00101-X","article-title":"Inhibition of telomerase by BIBR1532 and related analogues","volume":"13","author":"Barma","year":"2003","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"6958","DOI":"10.1093\/emboj\/20.24.6958","article-title":"A highly selective telomerase inhibitor limiting human cancer cell proliferation","volume":"20","author":"Damm","year":"2001","journal-title":"EMBO J."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"15566","DOI":"10.1074\/jbc.M201266200","article-title":"Mechanism of human telomerase inhibition by BIBR1532, a synthetic, non-nucleosidic drug candidate","volume":"277","author":"Pascolo","year":"2002","journal-title":"J. Biol. Chem."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Tawfik, H.O., El-Hamaky, A.A., El-Bastawissy, E.A., Shcherbakov, K.A., Veselovsky, A.V., Gladilina, Y.A., Zhdanov, D.D., and El-Hamamsy, M.H. (2022). New genetic bomb trigger: Design, synthesis, molecular dynamics simulation, and biological evaluation of novel BIBR1532-related analogs targeting telomerase against non-small cell lung cancer. Pharmaceuticals, 15.","DOI":"10.3390\/ph15040481"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1021\/acs.jmedchem.2c01668","article-title":"Ligand-based design on the dog-bone-shaped BIBR1532 pharmacophoric features and synthesis of novel analogues as promising telomerase inhibitors with in vitro and in vivo evaluations","volume":"66","author":"Nafie","year":"2023","journal-title":"J. Med. Chem."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1021\/acs.jmedchem.3c01708","article-title":"Lead optimization of BIBR1591 to improve its telomerase inhibitory activity: Design and synthesis of four novel chemical series with in silico, in vitro, and in vivo preclinical assessments","volume":"67","author":"Mousa","year":"2024","journal-title":"J. Med. Chem."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"107843","DOI":"10.1016\/j.bioorg.2024.107843","article-title":"Multi-target rationale design of novel substituted N-phenyl-2-((6-phenylpyridazin-3-yl)thio)acetamide candidates as telomerase\/JAK1\/STAT3\/TLR4 inhibitors: In vitro and in vivo investigations","volume":"153","author":"Shaldam","year":"2024","journal-title":"Bioorg. Chem."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Culletta, G., Allegra, M., Almerico, A.M., Restivo, I., and Tutone, M. (2022). In silico design, synthesis, and biological evaluation of anticancer arylsulfonamide endowed with anti-telomerase activity. Pharmaceuticals, 15.","DOI":"10.3390\/ph15010082"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"104077","DOI":"10.1016\/j.bioorg.2020.104077","article-title":"Design, synthesis and SARs of novel telomerase inhibitors based on BIBR1532","volume":"102","author":"Liu","year":"2020","journal-title":"Bioorg. Chem."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"e16404","DOI":"10.7717\/peerj.16404","article-title":"BIBR1532 inhibits proliferation and enhances apoptosis in multiple myeloma cells by reducing telomerase activity","volume":"11","author":"Zhang","year":"2023","journal-title":"PeerJ"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.jconrel.2010.03.025","article-title":"Telomerase as an emerging target to fight cancer\u2014Opportunities and challenges for nanomedicine","volume":"146","author":"Philippi","year":"2010","journal-title":"J. Control. Release"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"e70250","DOI":"10.1002\/ardp.70250","article-title":"Designing telomerase inhibitors for cancer therapy: Mechanistic insights, medicinal chemistry strategies, challenges, and future directions","volume":"359","author":"Attia","year":"2026","journal-title":"Arch. Pharm."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1016\/j.str.2015.08.006","article-title":"Structural basis of telomerase inhibition by the highly specific BIBR1532","volume":"23","author":"Bryan","year":"2015","journal-title":"Structure"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Wang, Y., Liu, B., He, Y., and Feigon, J. (2026). Structures of human telomerase with BIBR1532 reveal novel mechanism of inhibition. Nat. Chem. Biol.","DOI":"10.1038\/s41589-026-02238-6"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J. Comput. Chem."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"3891","DOI":"10.1021\/acs.jcim.1c00203","article-title":"AutoDock Vina 1.2.0: New docking methods, expanded force field, and Python bindings","volume":"61","author":"Eberhardt","year":"2021","journal-title":"J. Chem. Inf. Model."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s13321-025-00973-x","article-title":"GNINA 1.3: The next increment in molecular docking with deep learning","volume":"17","author":"McNutt","year":"2025","journal-title":"J. Cheminform."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"084106","DOI":"10.1063\/1.2834918","article-title":"Systematic optimization of long-range corrected hybrid density functionals","volume":"128","author":"Chai","year":"2008","journal-title":"J. Chem. Phys."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"e70019","DOI":"10.1002\/wcms.70019","article-title":"Software update: The ORCA program system\u2014Version 6.0","volume":"15","author":"Neese","year":"2025","journal-title":"WIREs Comput. Mol. Sci."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"224108","DOI":"10.1063\/5.0004608","article-title":"The ORCA quantum chemistry program package","volume":"152","author":"Neese","year":"2020","journal-title":"J. Chem. Phys."},{"key":"ref_33","first-page":"82","article-title":"PyMOL: An open-source molecular graphics tool","volume":"40","author":"DeLano","year":"2002","journal-title":"CCP4 Newsl. Protein Crystallogr."}],"container-title":["Current Issues in Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1467-3045\/48\/9\/893\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T12:11:31Z","timestamp":1788264691000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1467-3045\/48\/9\/893"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,1]]},"references-count":33,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["cimb48090893"],"URL":"https:\/\/doi.org\/10.3390\/cimb48090893","relation":{},"ISSN":["1467-3045"],"issn-type":[{"value":"1467-3045","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,1]]}}}